Brain structural and functional alterations in MOG antibody disease

Zhizheng Zhuo1, Yunyun Duan1, Decai Tian2

  • 1Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, P.R. China/Tiantan Image Research Center, China National Clinical Research Center for Neurological Diseases, Beijing, P.R. China.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 15, 2020
PubMed
Abstract

Insights

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) causes brain structure and function changes, including hippocampus atrophy linked to disability. This study reveals distinct MRI alterations in MOGAD patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • The impact of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) on brain structure and function remains largely unknown.
  • Understanding these changes is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate multimodal brain MRI alterations in MOGAD.
  • To explore the clinical significance of these MRI findings.
  • To differentiate MOGAD from aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders (AQP4+NMOSD).

Main Methods:

  • Recruited 17 MOGAD, 20 AQP4+NMOSD, and 28 healthy controls (HC).
  • Utilized voxel-wise gray matter (GM) volume, fractional anisotropy (FA), mean diffusivity (MD), and degree centrality (DC) analyses.
  • Employed partial correlation and stepwise logistic regression for clinical associations and differential diagnosis.

Main Results:

  • MOGAD patients showed GM atrophy and white matter (WM) fiber disruption compared to HC.
  • Distinct patterns of GM volume and DC alterations were observed in MOGAD compared to AQP4+NMOSD.
  • Hippocampus/parahippocampus atrophy correlated with disability and cognitive impairment.

Conclusions:

  • MOGAD is associated with unique structural and functional brain alterations.
  • Hippocampal atrophy is a key finding linked to clinical disability and cognitive deficits in MOGAD.
  • Multimodal MRI, particularly FA and DC, can accurately differentiate MOGAD from AQP4+NMOSD.